Shangri-La is a modern hybrid strain whose lineage is sparsely documented. While 9lb Hammer is noted as a parent, the strain's specific cross and breeder origin remain officially unconfirmed in public records. Because its history is thin, its development remains a subject of speculation among growers, as no official breeder description provides a narrative for its creation. Cultivators report that it is moderately difficult to grow, though it remains viable in both indoor and outdoor environments. With a flowering time of 60 days, the strain is recognized for producing a high yield.

The terpene profile of Shangri-La is led by limonene, followed by nerolidol, caryophyllene, linalool, beta-pinene, pinene, humulene, myrcene, bisabolol, camphene, terpinolene, caryophyllene-oxide, and isopulegol. This complex chemical composition likely creates a multifaceted sensory experience, though the exact dominance and interplay of these compounds are an estimated projection based on available lab data. Users should anticipate a nuanced aromatic profile, as the presence of these various terpenes suggests a distinct scent and flavor composition that spans from citrus-forward notes to subtle, woody undertones.

Shangri-La functions as a THC-dominant variety, with an estimated average of 20.8 percent THC and effectively no CBD content. The effects are characterized consistently as relaxed, happy, and uplifted. Because of this profile, it is frequently utilized by consumers seeking relief from stress, pain, and symptoms related to sleep disturbances. There are no recorded notable offspring for this strain, marking it as a distinct, standalone addition to the modern hybrid landscape.